Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Total Current Liabilities: 2022-2025

Historic Total Current Liabilities for bioAffinity Technologies (BIAF) over the last 3 years, with Sep 2025 value amounting to $2.4 million.

  • bioAffinity Technologies' Total Current Liabilities fell 5.28% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year decrease of 5.28%. This contributed to the annual value of $3.1 million for FY2024, which is 38.13% up from last year.
  • Latest data reveals that bioAffinity Technologies reported Total Current Liabilities of $2.4 million as of Q3 2025, which was down 8.84% from $2.6 million recorded in Q2 2025.
  • Over the past 5 years, bioAffinity Technologies' Total Current Liabilities peaked at $3.4 million during Q1 2025, and registered a low of $775,151 during Q2 2023.
  • For the 3-year period, bioAffinity Technologies' Total Current Liabilities averaged around $2.2 million, with its median value being $2.3 million (2024).
  • In the last 5 years, bioAffinity Technologies' Total Current Liabilities spiked by 200.11% in 2024 and then declined by 5.28% in 2025.
  • Quarterly analysis of 4 years shows bioAffinity Technologies' Total Current Liabilities stood at $1.1 million in 2022, then surged by 97.41% to $2.2 million in 2023, then spiked by 38.13% to $3.1 million in 2024, then declined by 5.28% to $2.4 million in 2025.
  • Its Total Current Liabilities was $2.4 million in Q3 2025, compared to $2.6 million in Q2 2025 and $3.4 million in Q1 2025.